Brief: Guard Therapeutics Q2 Pre-Tax Loss At SEK 8.7 Mln
Aug 20 (Reuters) - Guard Therapeutics International AB
(publ) GUARD.ST :
* Q2 PRE-TAX LOSS SEK 8.7 MILLION VERSUS LOSS SEK 11.0
MILLION
YEAR AGO
Source text for Eikon: ID:
Further company coverage: GUARD.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Disruptive Pharma AB (publ)
See all newsBrief: Disruptive Pharma To Sell GTX Platform To Aurelia Invest AB Unit
Brief: Guard Therapeutics International Q2 Loss Before Tax SEK 4.4 Mln
Brief: Guard Therapeutics Gets Conditional Approval For Continued Listing
Brief: Guard Therapeutics International Initiates Deal Process For Gtx Platform
Brief: Guard Therapeutics Enters Conditional Deal For Reverse Takeover